Unigestion Holding SA lifted its stake in shares of Keurig Dr Pepper Inc. (NASDAQ:KDP – Free Report) by 1,220.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 92,089 shares of the company’s stock after acquiring an additional 85,117 shares during the quarter. Unigestion Holding SA’s holdings in Keurig Dr Pepper were worth $3,451,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Sequoia Financial Advisors LLC bought a new stake in Keurig Dr Pepper in the second quarter worth about $370,000. Wealth Enhancement Advisory Services LLC boosted its holdings in Keurig Dr Pepper by 10.4% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 15,700 shares of the company’s stock worth $524,000 after buying an additional 1,478 shares in the last quarter. Envestnet Portfolio Solutions Inc. grew its position in Keurig Dr Pepper by 16.0% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 87,606 shares of the company’s stock worth $2,926,000 after buying an additional 12,053 shares during the last quarter. Cigna Investments Inc. New increased its holdings in shares of Keurig Dr Pepper by 7.8% in the second quarter. Cigna Investments Inc. New now owns 11,109 shares of the company’s stock valued at $371,000 after buying an additional 803 shares in the last quarter. Finally, Swedbank AB lifted its position in shares of Keurig Dr Pepper by 1.7% during the 2nd quarter. Swedbank AB now owns 465,268 shares of the company’s stock valued at $15,540,000 after acquiring an additional 7,689 shares during the last quarter. Institutional investors own 85.23% of the company’s stock.
Insider Buying and Selling at Keurig Dr Pepper
In other Keurig Dr Pepper news, major shareholder Bevco B.V. Jab sold 69,000,000 shares of Keurig Dr Pepper stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $32.65, for a total value of $2,252,850,000.00. Following the transaction, the insider now directly owns 214,443,879 shares of the company’s stock, valued at $7,001,592,649.35. The trade was a 24.34 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 1.00% of the company’s stock.
Keurig Dr Pepper Stock Down 0.2 %
Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last issued its quarterly earnings data on Thursday, October 24th. The company reported $0.51 earnings per share for the quarter, meeting the consensus estimate of $0.51. The firm had revenue of $3.89 billion for the quarter, compared to analyst estimates of $3.92 billion. Keurig Dr Pepper had a net margin of 15.04% and a return on equity of 10.45%. The company’s revenue for the quarter was up 2.3% on a year-over-year basis. During the same quarter last year, the firm earned $0.48 earnings per share. Equities research analysts forecast that Keurig Dr Pepper Inc. will post 1.92 EPS for the current fiscal year.
Keurig Dr Pepper Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, January 17th. Shareholders of record on Friday, January 3rd will be issued a dividend of $0.23 per share. This represents a $0.92 annualized dividend and a yield of 2.74%. Keurig Dr Pepper’s dividend payout ratio (DPR) is currently 55.76%.
Analysts Set New Price Targets
A number of equities analysts recently issued reports on KDP shares. Wells Fargo & Company cut their target price on Keurig Dr Pepper from $43.00 to $42.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Jefferies Financial Group dropped their price target on Keurig Dr Pepper from $42.00 to $41.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. Royal Bank of Canada upped their price objective on shares of Keurig Dr Pepper from $41.00 to $42.00 and gave the company an “outperform” rating in a research note on Friday, October 25th. Citigroup decreased their target price on shares of Keurig Dr Pepper from $43.00 to $40.00 and set a “buy” rating for the company in a report on Friday, October 25th. Finally, Barclays cut their price target on shares of Keurig Dr Pepper from $41.00 to $39.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Seven equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, Keurig Dr Pepper presently has a consensus rating of “Moderate Buy” and a consensus price target of $38.36.
View Our Latest Research Report on KDP
Keurig Dr Pepper Profile
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Featured Stories
- Five stocks we like better than Keurig Dr Pepper
- Stock Market Sectors: What Are They and How Many Are There?
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
- How to invest in marijuana stocks in 7 steps
- Why Betting on Oil Over Gold Could Pay Off Big in 2025
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Why MongoDB’s Drop Could Be Your Best Buy Opportunity for 2025
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.